EGFR and neoplasm: These PLGA-PEG/DOX@anti-EGFR nano-micelles were found to significantly improve TNBC treatment outcomes, inhibiting tumor growth while reducing treatment-related toxicity owing to the enhanced EGFR-mediated targeting and UMC-induced vascular permeability.